← Back to Search
Curcumin-Loaded Polymeric Nanoparticle: A Promising Route For The Treatment Of Cancer
Chinmayee Saikia, M. Sarmah, M. Das, Anand M. Ramteke, T. Maji
Published 2015 · Chemistry
Save to my Library
Download PDFAnalyze on Scholarcy
This paper references
Anti-tumour studies of metal chelates of synthetic curcuminoids.
V. D. John (2002)
Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo.
P. Anand (2010)
Surface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapy.
S. Thamake (2011)
Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification
S. Chono (2007)
Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat
P. Suresh Babu (2005)
Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods.
Y. Qiu (2010)
Native and β-cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer
S. Rahman (2012)
Optimization of the preparation of loperamide-loaded poly (L-lactide) nanoparticles by high pressure emulsification-solvent evaporation.
M. Ueda (1997)
Oxygen radical scavenging activity of curcumin
Elizabeth Kunchandy (1990)
Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications.
L. Mazzarino (2012)
In vivo evaluation of curcumin-loaded nanoparticles in a A549 xenograft mice model.
H. Yin (2013)
p-Nitrophenetole deethylase activity of rat liver microsomes entrapped in polyelectrolyte capsules.
C. Jung (1987)
Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations.
K. Letchford (2008)
Functional magnetic particles for medical application.
M. Shinkai (2002)
Pharmacology of diferuloyl methane (curcumin), a non‐steroidal anti‐inflammatory agent *
R. C. Srimal (1973)
Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery.
N. S. Rejinold (2011)
Modulatory effect of Henna leaf (Lawsonia inermis) on drug metabolising phase I and phase II enzymes, antioxidant enzymes, lipid peroxidation and chemically induced skin and forestomach papillomagenesis in mice
Trisha Dasgupta (2004)
The aggregation behavior of poly-(oxyethylene)-poly-(oxypropylene)-poly-(oxyethylene)-block-copolymers in aqueous solution
G. Wanka (1990)
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.
C. Gillett (1994)
Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.
Yeonhee Yun (2013)
Protein Precoating of Polylactide Microspheres Containing a Lipophilic Immunopotentiator for Enhancement of Macrophage Phagocytosis and Activation
Y. Tabata (2004)
Efficacy and irritancy of enhancers on the in‐vitro and in‐vivo percutaneous absorption of curcumin
Jia-You Fang (2003)
A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin
Soheil Zorofchian Moghadamtousi (2014)
Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly (N-isopropylacrylamide) nanocarrier for curcumin drug delivery.
N. S. Rejinold (2011)
Development and In Vitro Evaluation of Surface Modified Poly(lactide-co-glycolide) Nanoparticles with Chitosan-4-Thiobutylamidine
V. Grabovac (2007)
High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin.
Zengshuan Ma (2007)
Study of the Gelation Process of Polyethylene Oxidea -Polypropylene Oxideb -Polyethylene Oxidea Copolymer (Poloxamer 407) Aqueous Solutions
Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications
Murali M Yallapu (2012)
Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.
J. Adélaide (1995)
Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone.
K. Thompson (2004)
Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
S. Shankar (2007)
Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1.
A. Abusnina (2011)
Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis.
M. Cruz-Correa (2006)
Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1.
H. Chen (2008)
Manganese complexes of curcumin and its derivatives: evaluation for the radical scavenging ability and neuroprotective activity.
O. Vajragupta (2003)
Preparation and evaluation of the effect of particle size on the properties of chitosan-montmorillonite nanoparticles loaded with isoniazid
Nibedita Banik (2012)
Injectable sustained release microparticles of curcumin: a new concept for cancer chemoprevention.
Komal Shahani (2010)
Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells
Wanisa Punfa (2012)
Curcumin Suppresses the Paclitaxel‐Induced Nuclear Factor‐κB in Breast Cancer Cells and Potentiates the Growth Inhibitory Effect of Paclitaxel in a Breast Cancer Nude Mice Model
H. J. Kang (2009)
Curcumin as a promising anticandidal of clinical interest.
K. Neelofar (2011)
The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse
G. Lim (2001)
A study on the fate of curcumin in the rat.
B. Wahlström (1978)
Nanoparticle-mediated cellular response is size-dependent.
W. Jiang (2008)
Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin.
V. Kakkar (2011)
Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer
L. Li (2007)
Ueber Curcumin, den Farbstoff der Curcumawurzel
F. Daube (1870)
Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer.
D. Prajakta (2009)
Phase I Clinical Trial of Oral Curcumin
R. Sharma (2004)
Crosslinked thiolated starch coated Fe3O4 magnetic nanoparticles: Effect of montmorillonite and crosslinking density on drug delivery properties
Chinmayee Saikia (2014)
Curcumin delivery by methoxy polyethylene glycol-poly(caprolactone) nanoparticles inhibits the growth of C6 glioma cells.
Junfei Shao (2011)
Preliminary study on antirheumatic activity of curcumin (diferuloyl methane).
S. D. Deodhar (1980)
Optimization of polyalkylcyanoacrylate nanoparticle preparation: Influence of sulfur dioxide and pH on nanoparticle characteristics
F. Lescure (1992)
Pharmacology of Curcuma longa.
H. P. Ammon (1991)
Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers.
K. Athanasiou (1996)
Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS.
Kuo-Yi Yang (2007)
Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell.
A. Singh (1996)
Cancer: Limitations of therapies exposed
O. Casanovas (2012)
Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer.
J. Shaikh (2009)
Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Murali M Yallapu (2010)
In vitro and in vivo evaluation of curcumin loaded lauroyl sulphated chitosan for enhancing oral bioavailability.
R. Shelma (2013)
Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells.
Srinivas Ganta (2009)
Prevention and Treatment of Pancreatic Cancer by Curcumin in Combination With Omega-3 Fatty Acids
M. Swamy (2008)
Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53.
Myung-Jin Park (2002)
Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
A. Mukerjee (2009)
Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma.
S. Dhule (2012)
Influence of molecular weight on oral absorption of water soluble chitosans.
S. Chae (2005)
Highly active anticancer curcumin analogues.
Cara A Mosley (2007)
Rapid uptake of gold nanorods by primary human blood phagocytes and immunomodulatory effects of surface chemistry.
M. Bartneck (2010)
Oxidation of polyethylene glycols by alcohol dehydrogenase.
D. Herold (1989)
Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells.
A. Sahu (2008)
Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.
G. Shoba (1998)
Therapeutic potential of curcumin in gastrointestinal diseases.
S. A. Rajasekaran (2011)
Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities.
M. Suzuki (2005)
Chitosan chemistry and pharmaceutical perspectives.
M. Kumar (2004)
Galactosylated chitosan-polycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin.
N. Zhou (2013)
Nanosized magnetofluorescent Fe3O4-curcumin conjugate for multimodal monitoring and drug targeting
L. Tran (2010)
Effect of Cyclodextrin Complexation of Curcumin on its Solubility and Antiangiogenic and Anti-inflammatory Activity in Rat Colitis Model
Vivek R. Yadav (2009)
Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis.
N. Arber (1996)
Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells.
A. Sahu (2008)
Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells
H. W. Chen (1998)
Progress in cancer chemoprevention: development of diet-derived chemopreventive agents.
G. Kelloff (2000)
Therapeutic efficacy evaluation of curcumin on human oral squamous cell carcinoma xenograft using multimodalities of molecular imaging.
Yu-Chuan Lin (2010)
Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique
D. Chirio (2011)
Curcumin protects against 4-hydroxy-2-trans-nonenal-induced cataract formation in rat lenses.
S. Awasthi (1996)
Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone
R. Muzzarelli (2009)
Bioavailability of curcumin: problems and promises.
P. Anand (2007)
Mucoadhesive polymeric platforms for controlled drug delivery.
G. Andrews (2009)
Oral nanoparticle-based antituberculosis drug delivery to the brain in an experimental model.
R. Pandey (2006)
Pluronic F127 gel formulations of deslorelin and GnRH reduce drug degradation and sustain drug release and effect in cattle.
J. Wenzel (2002)
Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages.
M. Pan (2000)
Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin.
A. Liu (2006)
Influence of polysaccharide coating on the interactions of nanoparticles with biological systems.
C. Lemarchand (2006)
Biotransformation of curcumin through reduction and glucuronidation in mice.
M. Pan (1999)
Influence of retinol deficiency and curcumin/turmeric feeding on tissue microsomal membrane lipid peroxidation and fatty acids in rats
S. Kaul (2004)
Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system
T. Neuberger (2005)
Curcumin Inhibits Prosurvival Pathways in Chronic Lymphocytic Leukemia B Cells and May Overcome Their Stromal Protection in Combination with EGCG
A. Ghosh (2009)
Development and characterization of new insulin containing polysaccharide nanoparticles.
B. Sarmento (2006)
Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
J. Bártková (1995)
Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences.
G. Garcea (2005)
Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells.
R. Das (2010)
Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles
Runliang Feng (2012)
Polymeric micelles - a new generation of colloidal drug carriers.
M. Jones (1999)
Parameters influencing the stealthiness of colloidal drug delivery systems.
A. Vonarbourg (2006)
Photophysical Studies on Binding of Curcumin to Bovine Serum Albumin¶
A. Barik (2003)
Antioxidant, antimutagenic and antibacterial activities of curcumin-β-diglucoside
K. S. Parvathy (2009)
Colon targeted curcumin delivery using guar gum
A. Singhal (2010)
Polymeric micelles for parenteral delivery of curcumin: Preparation, characterization and in vitro evaluation
L. Song (2011)
Efficient water soluble O-carboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells
A. Anitha (2011)
Modification of curcumin with polyethylene glycol enhances the delivery of curcumin in preadipocytes and its antiadipogenic property.
C. Y. Kim (2011)
Liposomal delivery system enhances anti-inflammatory properties of curcumin.
Purusotam Basnet (2012)
Curcuminoids Inhibit the Angiogenic Response Stimulated by Fibroblast Growth Factor-2, Including Expression of Matrix Metalloproteinase Gelatinase B*
R. Mohan (2000)
Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate–chitosan nanoparticles
A. Anitha (2011)
Microencapsulation of isoniazid in genipin-crosslinked gelatin-A–κ-carrageenan polyelectrolyte complex
N. Devi (2010)
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.
S. Laurent (2008)
Anticancer potential of curcumin: preclinical and clinical studies.
B. Aggarwal (2003)
Calcitonin and Insulin in Isobutylcyanoacrylate Nanocapsules: Protection Against Proteases and Effect on Intestinal Absorption in Rats
P. J. Lowe (1994)
Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.
G. Bar-Sela (2010)
Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53.
S. Han (1999)
Design and development of water-soluble curcumin conjugates as potential anticancer agents.
A. Safavy (2007)
Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration
G. Garcea (2004)
Prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigen.
M. Caputi (1999)
Magnetic nanoparticles for gene and drug delivery
S. McBain (2008)
Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins.
A. W. Richter (1983)
Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes.
Z. Sui (1993)
Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis.
S. Perkins (2002)
Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells
A. Choi (2007)
Molecular properties of WHO essential drugs and provisional biopharmaceutical classification.
N. A. Kasim (2004)
Colon Targeted Curcumin Delivery Using Guar Gum
Edwin J. Elias (2010)
Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides.
S. Verma (1997)
Characterization of N-trimethyl chitosan/alginate complexes and curcumin release.
A. Martins (2013)
Chitosan-dextran Sulfate Nanoparticles for Delivery of an Anti-angiogenesis Peptide
Y. Chen (2004)
Studien über Curcumin
V. Lampe (1913)
Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
K. Y. Win (2005)
Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents.
H. Ohtsu (2002)
Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake.
J. Liu (2012)
This paper is referenced by
Chitosan-Polycaprolactone Blend Sponges for Management of Chronic Osteomyelitis: A Preliminary Characterization and In vitro Evaluation.
V. Pawar (2019)